BOSTON — April 20, 2016 — Dr. Fang Xie, patent attorney and of counsel in Greenberg Traurig, LLP’s Life Sciences & Medical Technology Group, was a featured speaker for the webinar, “Patent Protection for Pharma and Biotechnology” on April 18, 2016. Hosted by The Knowledge Group, this live webcast covered the following topics:
- Notable Supreme Court Decisions Affecting Pharma and Biotech Industry
- Mayo Collaborative Servs. v. Prometheus Labs., Inc.
- Molecular Pathology v. Myriad Genetics
- Limelight Networks, Inc. v. Akamai Technologies, Inc.
- Patent Protection Challenges Post Mayo, Myriad and Limelight
- Best Strategies on Protecting Patent for Pharma and Biotech Innovation
- Up-to-date Legislative Trends on Pharma and Biotech Patents
Fang Xie, Ph.D., is of counsel in Greenberg Traurig, LLP’s Boston office where she focuses her practice on developing, evaluating, and enforcing intellectual property rights. She has broad experience in worldwide patent and trademark portfolio development, intellectual property due diligence, licensing and technology transfer, patentability and product clearance studies, patent infringement and validity analyses, freedom to operate evaluations, as well as intellectual property litigation and pre-litigation counseling. Dr. Xie’s primary technical areas include biotechnology, synthetic biology, and pharmaceuticals, with a focus on nucleic acid synthesis, protein and organism engineering, antibody and biologics/biosimilars, stem cell technology, regenerative medicine, biomarkers, genetic diagnostics, small molecule drugs, analytical chemistry, and cosmetics. She regularly works with clients in the life sciences sector, including biotechnology, pharmaceutical, and chemistry companies, as well as venture capital and institutional investors. Dr. Xie also frequently works with early-stage bio-pharmaceutical companies to enhance their IP position and develop licensing and partnership strategies.
According to its website, The Knowledge Group produces over 200 CLE CPE webcasts annually for the legal, tax, finance, risk, compliance, and human resources professions. The organization’s goal is to deliver a unique multilevel analysis of important issues affecting businesses in a highly focused format.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. One firm worldwide, GTLaw has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and among the Top 20 on the 2016 Am Law Global 100. Web: www.gtlaw.com Twitter: @GT_Law.